Aquestive Therapeutics (AQST) vs Tilray Brands (TLRY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Aquestive Therapeutics (AQST) has outperformed Tilray Brands (TLRY) over the past year, losing 23.2% versus a loss of 79.1%. Over five years, AQST leads with a +23.0% price change compared with -96.5% for TLRY. Aquestive Therapeutics is the larger company by market cap ($597.4 million vs $530.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AQST | TLRY |
|---|---|---|
| Share price | $4.76 | $3.59 |
| Market cap | $597.44M | $530.54M |
| 1-day change | +3.03% | -3.36% |
| YTD return | -26.32% | -60.24% |
| 1-year return | -23.23% | -79.13% |
| 5-year return | +23.00% | -96.49% |
| Forward P/E | — | 20.22 |
| EPS (TTM) | $-0.66 | $-1.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.55 | $20.20 |
| 52-week low | $2.93 | $3.38 |
| Distance from 52-week high | -36.95% | -82.23% |
| Analyst consensus | none | buy |
| Avg. price target upside | +96.01% | +99.44% |
| Average volume | 2.68M | 4.17M |
| Shares outstanding | 125.51M | 147.78M |
| Employees | 147 | 3,595 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AQST has outperformed TLRY by 55.9 percentage points over the past year.
About Aquestive Therapeutics
AQST stock →Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally.
Health Care · Biotechnology: Pharmaceutical Preparations · 147 employees
About Tilray Brands
TLRY stock →Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness.
Health Care · Medicinal Chemicals and Botanical Products · 3,595 employees
AQST vs TLRY FAQ
Which is bigger, Aquestive Therapeutics or Tilray Brands?
Aquestive Therapeutics (AQST) is larger, with a market capitalization of $597.44M compared with $530.54M for Tilray Brands (TLRY).
Which stock has performed better over the past year, AQST or TLRY?
AQST returned -23.23% over the past 12 months, compared with -79.13% for TLRY (price return, excluding dividends). Past performance does not predict future results.
Are Aquestive Therapeutics and Tilray Brands in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for Aquestive Therapeutics and Medicinal Chemicals and Botanical Products for Tilray Brands.